1369996-08-6

Upstream product

• 1369595-32-3 C₅₁H₅₃N₇O₅ 
• 1369595-29-8 C₄₅H₄₈ClN₇O₅ 
• 1369595-28-7 C₃₃H₃₆B₂ClNO₅ 
• 1369595-27-6 C₂₁H₁₂Br₂ClNO 
• 1240893-76-8 (S)-2-(4,5-dibromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1246471-94-2 5-bromo-2-(5-bromo-1H-indol-2-yl)phenol 
• 1369594-43-3 C₁₄H₁₂Br₂N₂O 
• 1007882-59-8 (S)-2-(4-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1007882-58-7 (S)-tert-butyl 2-(1H-imidazol-2-yl)pyrrolidine-1-carboxylate 
• 69610-41-9 Boc-L-Pro-H 
• 69610-40-8 N-(tert-butoxycarbonyl)-L-prolinol 
• 30186-18-6 4'-bromo-2'-hydroxyacetophenone 

Relevant academic research and scientific papers

TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION

Tetracyclic indole derivatives of formula (I), pharmaceutically acceptable salts and the pharmaceutical compositions thereof are provided, wherein A, A', G, R1, R15, U, V, V, W, W, X, X', Y, Y' are as defined in the invention. Use of these derivatives for treating hepatitis C virus (HCV) infection is also provided.